- 8 hrs ago Microcytic Anemia: Symptoms, Causes, Risk Factors, Treatment, And Prevention
- 17 hrs ago Sebaceous Horn (Devil’s Horn): Causes, Symptoms, Risk Factors, Treatment, And Prevention
- 18 hrs ago Exclusive: Fashion Guru Prasad Bidapa Shares The Secret For Glowing And Flawless Skin
- 19 hrs ago Priyanka Chopra Jonas, Kareena Kapoor Khan, And Other Best And Worst Dressed Celebs Of This Week
- News Engineering Jobs: POWERGRID announces Executive Trainee vacancies; How to apply
- Movies WHAAT? Salman Khan's LIP-LOCK Scenes With Alia Bhatt Lead To Indifference Between Him & Mr Bhansali?
- Sports Pro Kabaddi League 2019: Match 94: Telugu Titans Vs Dabang Delhi: Dream 11 Prediction, Fantasy Tips
- Technology Tata Sky On WhatsApp: Check Balance, Add Packs And More
- Automobiles Tata Motors Announces Discounts & Benefits Of Up To Rs 1.50 Lakh On Select Models
- Finance Govt Employees Will Get Housing Advance At Lower Interest Rates
- Education HSSC Clerk Admit Card 2019 Released
- Travel Cycling for beginners: The basics any beginner cyclists should know
Alzheimer's disease is an irreversible, progressive brain disorder that causes the brain cells to degenerate and die, resulting in a decline in thinking, memory, behavioural and social skills.
According to the Alzheimer's Association, more than 4 million people in India have some form of dementia. It is estimated that at least 44 million people are living with dementia.
New treatments are still under way to stop, slow or prevent Alzheimer's disease and some of them have been unsuccessful.
The brain disorder is caused by the accumulation of plaque deposits in the brain, which eventually becomes toxic to brain cells. These plaque deposits are one of the biggest problems that are coming in the way to finding a cure for Alzheimer's disease because it's impossible to clear out the deposits from the brain tissue.
However, in a very recent breakthrough for Alzheimer's disease, United Neuroscience, a biotech company founded by Dr Chang Yi Wang, a prolific bio-inventor, her daughter Mei Mei Hu, and son-in-law, Louis Reese announced the results of Phase II a clinical trial on UB-311, an Alzheimer's vaccine.
This vaccine contains synthetic versions of amino acid chains that stimulate the antibodies to attack Alzheimer's protein in the blood, without causing any side effects. The antibodies were analysed in some patients and there was an almost 100% response rate.
Researchers believe that the vaccine can delay the onset of Alzheimer's disease by five years.
Currently, the company is working on the next clinical trial of the vaccine and its goal is to create innumerable vaccines that will be used to protect people from chronic illnesses.